Similar articles for PMID: 34099468

Year	Number of Results
2002	1
2003	1
2004	1
2005	1
2006	3
2007	1
2009	2
2010	1
2011	2
2012	3
2013	5
2014	5
2015	12
2016	14
2017	15
2018	6
2019	12
2020	15
2021	11
2022	1
2023	1
2024	0

1

Advances in the management of pancreatic ductal adenocarcinoma.

O'Kane GM, Ladak F, Gallinger S. O'Kane GM, et al. CMAJ. 2021 Jun 7;193(23):E844-E851. doi: 10.1503/cmaj.201450. CMAJ. 2021. PMID: 34099468 Free PMC article. Review. No abstract available.

2

Biomarkers for subtypes of pancreatic ductal adenocarcinoma.

Venkatesan P. Venkatesan P. Lancet Oncol. 2017 Dec;18(12):e718. doi: 10.1016/S1470-2045(17)30842-2. Epub 2017 Nov 9. Lancet Oncol. 2017. PMID: 29129444 No abstract available.

3

Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma.

Hori S, Shimada K, Ino Y, Oguro S, Esaki M, Nara S, Kishi Y, Kosuge T, Hattori Y, Sukeda A, Kitagawa Y, Kanai Y, Hiraoka N. Hori S, et al. Virchows Arch. 2016 Dec;469(6):621-634. doi: 10.1007/s00428-016-2026-6. Epub 2016 Oct 5. Virchows Arch. 2016. PMID: 27709361

4

Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.

Loehrer AP, Kinnier CV, Ferrone CR. Loehrer AP, et al. Adv Surg. 2016 Sep;50(1):115-28. doi: 10.1016/j.yasu.2016.03.010. Epub 2016 Jul 7. Adv Surg. 2016. PMID: 27520867 Review. No abstract available.

5

The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy.

Yamada D, Eguchi H, Iwagami Y, Asaoka T, Noda T, Kawamoto K, Gotoh K, Kobayashi S, Mori M, Doki Y. Yamada D, et al. Surg Today. 2018 Oct;48(10):952-962. doi: 10.1007/s00595-018-1674-3. Epub 2018 May 17. Surg Today. 2018. PMID: 29770847

6

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.

McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. McGuigan A, et al. World J Gastroenterol. 2018 Nov 21;24(43):4846-4861. doi: 10.3748/wjg.v24.i43.4846. World J Gastroenterol. 2018. PMID: 30487695 Free PMC article. Review.

7

[Therapy in pancreatic cancer - and still it moves along!].

Ettrich TJ, Perkhofer L, Seufferlein T. Ettrich TJ, et al. Dtsch Med Wochenschr. 2015 Apr;140(7):508-11. doi: 10.1055/s-0041-101154. Epub 2015 Mar 31. Dtsch Med Wochenschr. 2015. PMID: 25826035 German.

8

Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.

Alemi F, Alseidi A, Scott Helton W, Rocha FG. Alemi F, et al. Curr Probl Surg. 2015 Sep;52(9):362-98. doi: 10.1067/j.cpsurg.2015.07.003. Epub 2015 Jul 17. Curr Probl Surg. 2015. PMID: 26363649 Review. No abstract available.

9

Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma.

Li B, Shen S, You S, Zhang G, Gao S, Shi X, Wang H, Yin X, Xu X, Guo S, Jin G. Li B, et al. BMC Cancer. 2021 May 26;21(1):612. doi: 10.1186/s12885-021-08380-9. BMC Cancer. 2021. PMID: 34034684 Free PMC article.

10

Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.

Schmocker RK, Delitto D, Wright MJ, Ding D, Cameron JL, Lafaro KJ, Burns WR, Wolfgang CL, Burkhart RA, He J. Schmocker RK, et al. J Am Coll Surg. 2021 Apr;232(4):405-413. doi: 10.1016/j.jamcollsurg.2020.11.018. Epub 2020 Dec 16. J Am Coll Surg. 2021. PMID: 33338577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year